Filing Details

Accession Number:
0001214659-25-002804
Form Type:
13G Filing
Publication Date:
2025-02-13 19:00:00
Filed By:
Tang Capital Management
Company:
Monopar Therapeutics (NASDAQ:MNPR)
Filing Date:
2025-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
TANG CAPITAL MANAGEMENT, LLC 0 0 0%
KEVIN TANG 0 0 0%
TANG CAPITAL PARTNERS, LP 0 0 0%
TANG CAPITAL PARTNERS III, INC 0 0 0.0%
TANG CAPITAL PARTNERS IV, INC 0 0 0.0%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
TANG CAPITAL MANAGEMENT, LLC
 
Signature:/s/ Kevin Tang
Name/Title:Manager
Date:02/14/2025
 
KEVIN TANG
 
Signature:/s/ Kevin Tang
Name/Title:Self
Date:02/14/2025
 
TANG CAPITAL PARTNERS, LP
 
Signature:/s/ Kevin Tang
Name/Title:Manager, Tang Capital Management, LLC, General Partner
Date:02/14/2025
 
TANG CAPITAL PARTNERS III, INC
 
Signature:/s/ Kevin Tang
Name/Title:Chief Executive Officer
Date:02/14/2025
 
TANG CAPITAL PARTNERS IV, INC
 
Signature:/s/ Kevin Tang
Name/Title:Chief Executive Officer
Date:02/14/2025